Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.39
Delayed Data
As of Mar 26
 -0.01 / -0.71%
Today’s Change
1.19
Today|||52-Week Range
2.09
0.00%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.40
Today’s open1.38
Day’s range-- - --
Volume1,001,817
Average volume (3 months)1,300,373
Market cap$263.7M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...-0.16-1.80%
SNTASynta Pharmaceutical...-0.07-2.95%
ECYTEndocyte Inc+0.12+1.95%
VVUSVIVUS Inc-0.12-4.60%
Data as of 03/26/2015

Financials

Next reporting dateJuly 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account